Siemens Healthcare agrees to sell microbiology business to Beckman Coulter

Stronger concentration of Diagnostics Division on core business

17-Jul-2014 - Germany

Siemens Healthcare is selling its microbiology business to Beckman Coulter Inc., a wholly owned subsidiary of Danaher Corporation. The activities of the microbiology business include systems for the identification and antibiotic susceptibility testing (ID/AST) of microorganisms. The decision enables Siemens Healthcare to focus on its core in-vitro business within the Diagnostics Division and is also in alignment with Siemens – Vision 2020. It has been agreed not to disclose details of this transaction. The transaction is subject to applicable regulatory approvals..

Other news from the department business & finance

Most read news

More news from our other portals

See the theme worlds for related content